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• Solution-phase synthesis S2 • Solid-phase synthesis S6 • Determinations of diastereopurity S10 • 1 H and 13 C NMR spectra for building blocks prepared in solution S14 • 1 H NMR and LCMS spectra for peptides prepared by SPPS S26 mmol) and the reaction stirred at reflux for 1 h. The reaction solution was cooled to rt and concentrated under vacuum. The crude residue was then dissolved in 2 mL of DCM and 20 mL of hexane was added to induce precipitation of the desired product. After further washing with hexanes, the precipitate was filtered and dried under vacuum to give Fmoc-Asp(Me)-Cl as a white powder (506 mg, 1.31 mmol, 96%). 1 H NMR (400 MHz, CDCl 3 ) δ 7.77 (d, J = 7.5 Hz, 2H), 7.59 (d, J = 7.5 Hz, 2H), 7.41 (t, J = 7.4 Hz, 2H), 7.32 (t, J = 7.3 Hz, 2H), 5.92 (d, J = 9.4 Hz, 1H), 4.88 (dt, J = 9.2, 4.5 Hz, 1H), 4.53 (dd, J = 10.6, 6.9 Hz, 1H), 4.39 (dd, J = 10.6, 7.1 Hz, 1H), 4.24 (t, J = 6.8 Hz, 1H), 3.75 (s, 3H), 3.23 (dd, J = 17.7, 4.8 Hz, 1H), 2.92 (dd, J = 17.7, 4.3 Hz, 1H).
Synthesis of 2c and 2d via acid chloride coupling. 2,4,6-collidine (2.40 mmol) and Fmoc-(D)Asp(OMe)-Cl (0.80 mmol) were added to a solution of (N'-Boc)-Nα-amino alanine methyl ester or (N'-Boc)-Nα-amino glycine methyl ester (0.4 mmol) in 7 mL of THF at rt. After stirring for 24 h, the reaction was diluted with EtOAc and washed with 1 M aq. HCl, sat. aq. NaHCO 3 and brine. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed in vacuo, and the residue was purified by silica gel flash chromatography (5%-40% EtOAc/hexanes) to give the product as a colorless oil.
Fmoc-(D)Asp(Me)-(N-NHBoc)Gly-OMe (2c).
1 H NMR (400 MHz, CDCl 3 ) δ 7.76 (d, J = 7.5 Hz, 2H), 7.59 (d, J = 7.4 Hz, 2H), 7.46 (s, 1H), 7.40 (t, J = 7.5 Hz, 2H), 7.31 (t, J = 7.3 Hz, 2H), 5.71 (bs, 1H), 5.23 (dd, J = 13.7, 6.4 Hz, 1H), 4.35 (p, J = 10.6 Hz, 2H), 4.22 (t, J = 7.2 Hz, 1H), 3.74 (s, 3H), 3.70 (s, 3H), 2.86 (dd, J = 16.0, 5.7 Hz, 1H), 2.74 -2.61 (m, 1H), 1.47 (s, 9H) (Note: signals for the Namino glycine Hα protons were curiously absent from the NMR spectrum, presumably due to significant broadening. These signals reappeared clearly upon formation of the Tpd in the 1 H NMR spectrum of 3); 13 C NMR (101 MHz, CDCl 3 ) δ 173. 4, 170.7, 169.1, 155.6, 153.7, 143.8, 143.7, 141.2, 127.7, 127.1, 125.2, 120.0, 82.9, 67.3, 52.5, 52.1, 48.6, 47.4, 47.0, 37.3, 28 3, 172.3, 170.8, 155.8, 155.0, 143.8, 143.7, 141.2, 127.7, 127.1, 125.2, 120.0, 82.3, 67.4, 54.6, 52.6, 52.1, 48.1, 47.0, 36.8, 28.0, 13.8; 
Synthesis of Fmoc-(D)
Tpd-Gly-OMe (3) from 2c. Compound 2c (148 mg, 0.25 mmol) was treated with 2 mL of 95:5 TFA:DCM for 4 h at rt. After removing solvent under vacuum, the residue was treated with DIEA (96 µL, 0.74 mmol), DIC (31 µL, 0.25 mmol), and DMAP (6.0 mg, 50 µmol) in 4 mL of DCM at rt. After stirring 8 h, the reaction was diluted with EtOAc and washed with 1 M aq. HCl, sat. aq NaHCO 3 and brine. The organic layer was dried over anhydrous MgSO 4 , the solvent was removed in vacuo, and the residue was purified by silica gel flash chromatography (20%-80% EtOAc/hexanes) to give the product as a thick oil (34 mg, 32%).
1 H NMR (400 MHz, CDCl 3 ) δ 9.43 (bs, 1H), 7.69 (d, J = 7.5 Hz, 2H), 7.52 (d, J = 5.0 Hz, 2H), 7.33 (t, J = 7.5 Hz, 2H), 7.24 (t, J = 7. 3, 167.7, 167.1, 155.6, 143.7, 143.6, 141.3, 141.2, 127.8, 127.1, 125.1, 120.0, 67.3, 52.9, 48.7, 47.8, 47.0, 34.9 
Tpd-Gly-OMe (3) from 2d. Compound 2d (143 mg, 0.26 mmol) was treated with 2 mL of 1:3 TFA:DCM for 2 hours at rt. After removing solvent under vacuum, the residue was taken up in 5 mL of toluene and heated at 100 o C for 3 hours. The reaction was cooled to rt and stirred for 12 h. The solvent was removed under vacuum and the residue was purified by silica gel flash chromatography (20%-80% EtOAc/hexanes) to give the product as a thick oil (57 mg, 53%). Spectral data matched those above.
Synthesis of α-hydroxy esters (10b-f). Diazotization of H-(D)Leu-OH, H-(D)Val-OH, H-(D)alloIle-OH, and H-(D)Ser(tBu)-OH was performed using a modification to the previously reported procedure (Deechongkit et al. Org. Lett. 2004, 6, 497) . Generally, the D-amino acid (1.0 mmol) in 5 mL of a 1:4 AcOH:water solution at 0 o C was treated with 2 M aq. NaNO 2 (2.0 mmol). The reaction was allowed to warm to rt and stirred for 24 h. The mixture was concentrated under reduced pressure and acidified to pH 2 with 1M aq. HCl. The aqueous layer was extracted with EtOAc (exhaustively as indicated by TLC). The combined organic layers were dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure. (R)-2-Hydroxy-3-phenylpropionic acid was purchased from a commercial source and use directly in the subsequent esterification. The α-hydroxy acid (1.0 mmol) was dissolved in 5 mL DMF and treated with K 2 CO 3 (5.0 mmol) and iodomethane (3.0 mmol). The reaction was stirred for 24 h at rt, then partitioned between water and Et 2 O. The organic layer was washed with water and 1 M aq. HCl, dried over anhydrous Na 2 SO 4 , and concentrated under reduced pressure at 33 o C. The resulting liquids were purified by flash chromatography over silica gel (5-30% Et 2 O/hexanes) to afford the corresponding α-hydroxy esters (note: care must be taken during concentration steps and drying of 10c-d due to their enhanced volatility). 
(S)-Methyl 2-hydroxy-3-phenylpropanoate (10b), (S)-methyl 2-hydroxy-4-methylpentanoate (10c), and (S)-methyl 2-hydroxy-3-methylbutanoate (10d)
.
Synthesis of (N'-Boc)-α-hydrazo acids (11a-f).
A solution of 10 (1.0 mmol) in 3 mL of DCM at 0 o C was treated with trifluoromethanesulfonic anhydride (1.3 mmol) and 2,6-lutidine (2.0 mmol). The reaction was stirred at 0 o C until TLC showed consumption of the starting material (typically 1-2 h). Solid t-butyl carbazate (2.0 mmol) was added and the reaction was stirred at 0 o C for 4 h, then at rt for 15 h. The reaction mixture was diluted with DCM and washed with water, brine, and 1 M aq. HCl. The resulting organic layer was dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure. Purification by flash chromatography over silica gel (10-30% EtOAc/hexanes) afforded the intermediate
The methyl ester above (1.0 mmol) was dissolved in 2 mL of a 1:1 THF:water solution, treated with LiOH . H 2 O (2.0 mmol), and stirred at rt until TLC indicated completion (2-3 h). The mixture was concentrated, and the aqueous layer was washed with Et 2 O. The aqueous layer was then acidified to pH 2 with 1 M aq. HCl and extracted with EtOAc (extraction monitored by TLC). The combined organic layers were concentrated under reduced pressure to afford the desired N'-Boc-α-hydrazo acid.
(N'-Boc)-N-amino alanine (11a). Spectra for 11a matched those previously reported (Acherar et al., Eur. J. Org. Chem. 2013, 5603) . 4, 172.3, 156.6, 135.9, 129.2, 128.5, 126.6, 81.0, 77.3, 60.9, 52.45, 37.8, 28.3, 16.9 
(N'-Boc)-N-amino phenylalanine (11b

SOLID-PHASE SYNTHESIS
General solid-phase synthesis notes. Solid-phase peptide synthesis was carried out on Fmoccapped polystyrene rink amide MBHA resin (79 µmol/g loading, 100-200 mesh, 0.1 mmol scale). The following side-chain protected amino acid derivatives suitable for Fmoc SPPS were used: FmocTyr(tBu)-OH, Fmoc-Ser(tBu)-OH, Fmoc-Lys(Boc)-OH, Fmoc-Asn(Trt)-OH, Fmoc-Asp(tBu)-OH, Fmoc-Thr(tBu)-OH. Dry resin was washed with DMF 3x and allowed to swell in DMF for 2 h prior to use. All reactions were carried out using gentle agitation. Fmoc deprotection steps were carried out by treating the resin with a solution of 20% piperidine/DMF at 50 o C (15 min x 2). Coupling of Fmocprotected amino acids was effected using 5 equiv. HATU (0.2 M in DMF), 10 equiv. DIEA (0.4 M in DMF), and 5 equiv. of carboxylic acid in 5:1 DMF:DCM at 50 o C (1 h x 2). Acetylation of the peptide N-terminus was carried out using 10 equiv. of Ac 2 O and 20 equiv. of pyridine in DCM at rt (1 h x 2). After each reaction the resin was washed with DMF 3x, DCM 2x, then DMF 1x. Prior to cleavage, the resin was washed with MeOH 5x and dried thoroughly under vacuum. Compounds were cleaved by incubating the dried resin in 2 mL of 95:5 TFA:H 2 O at rt for 4 h. The cleavage mixture was filtered and the resin was rinsed with an additional 1 mL of cleavage solution. The filtrate was concentrated to remove the bulk of the TFA and the remaining residue was treated with 8 mL of cold Et 2 O to induce precipitation. The mixture was centrifuged and the supernatant was removed. The remaining solid was washed 2 more times with Et 2 O and dried under vacuum. The crude peptides were purified by RP-HPLC on a C 8 semi-preparative column using linear gradients of MeCN in 0.1% aq. formic acid, then lyophilized to afford white powders. All peptides were characterized by LC-MS (ESI), HRMS (ESI-TOF), and 1 H NMR.
Synthesis of Ac-Phe-(D)-Tpd-Gly-Tyr-NH 2 (5) via submonomer approach.
Compound 5 was synthesized on 0.1 mmole scale as described above with the following modifications. Introduction of the bromoacetic acid subunit was carried out using 5 equiv. DIC, and 5 equiv. of bromoacetic acid at rt in DMF (15 min x 2). After washing, the resulting immobilized bromoacetamide was reacted with a solution of t-butyl carbazate (2M in DMF) at 50 o C (18 h). The resin was washed and treated with 9 equiv. collidine and 3 equiv. 
Synthesis of Cα,Nα-disubstituted Tpd peptidomimetics (14-27).
Compounds 14-27 were synthesized as described above with the following modifications. Introduction of α-hydrazo acids 11a-f was carried out using 5 equiv. HATU (0.2 M in DMF), 10 equiv. DIEA (0.4 M in DMF), and 5 equiv. of carboxylic acid in 5:1 DMF:DCM at 50 o C (1 h x 2). After washing, the resin was treated with 9 equiv. collidine and 3 equiv. of Fmoc-Asp(Me)-Cl (D or L isomer) in THF at 50 o C (1 h x 3). Subsequent Fmoc deprotections, coupling of Fmoc-Phe-OH, acetylation, and cleavage/purification was performed as described above. Compound 12 was re-synthesized following the α-bromo acid route route below. The 1 H NMR spectrum (400 MHz in CDCl 3 ) exhibited a 1.6:1 mixture of diastereomers, as determined by integration of clearly resolved peaks for the methyl ester and the indicated Phe Hβ proton. In contrast, the method described in Scheme 4 afforded compound 12 with a > 20:1 d.r. based on NMR. Complete NMR spectra for pure 12 are also provided in the following section. 
